ZOETIS INC. - ZTS STOCK NEWS

Zoetis (NYSE: ZTS) will host a webcast and conference call to discuss its second quarter 2024 financial results on Tuesday, August 6, 2024, at 8:30 a.m. (ET). CEO Kristin Peck and CFO Wetteny Joseph will review the results and answer questions from financial analysts. The webcast will be accessible through the Zoetis investor website, with pre-registration information available now. A replay of the webcast will be available starting the same day.

Zoetis Foundation has announced a $3 million grant to the American Red Cross, to be used over six years for global disaster relief efforts. This grant will support the Annual Disaster Giving Program, aiding both domestic and international disaster response and preparedness. In addition, Zoetis has launched a consumer matching campaign with American Humane to support pets affected by natural disasters in the U.S.

Zoetis has a decade-long partnership with American Humane, focusing on animal safety in disaster situations, and they have contributed to the care of 1.3 million animals globally between 2021-2023. The collaboration includes operating emergency vehicles stocked with Zoetis pet medications and hosting pet preparedness clinics.

The Zoetis Foundation’s support aims to bolster the Red Cross' ability to respond to disasters and help communities prepare for future crises. This initiative is part of Zoetis' broader sustainability strategy, which has made significant impacts worldwide.

Zoetis released its 2023 Sustainability Report, highlighting advancements in its 'Driven to Care' strategy. Key achievements include:

1. Increasing volunteer work by 81% to 16,611 hours.

2. Supporting 28 initiatives with $8.3 million in grants across 19 countries.

3. Launching innovative diagnostics, vaccines, and parasiticides for livestock producers.

4. Utilizing over 30% renewable electricity with on-site solar arrays at seven facilities, aiming for 100% by 2030.

5. Replacing rabies vaccine packaging plastic with paperboard, reducing PVC use by 8.0 metric tons annually.

Zoetis invested $7 million in community programs, reaching 202,000 pet owners and impacting 91,000 animals. The company also received eight awards for fostering an inclusive culture and expanded its Leading@Zoetis program to over 2,000 leaders globally.

Zoetis aims to achieve carbon neutrality by 2030, reporting 32.6% renewable electricity use, completing 38 energy efficiency projects, and reducing Scope 1 and 2 emissions by 18.9% since 2021.

The Board of Directors at Zoetis (NYSE: ZTS) has announced a dividend of $0.432 per share for the third quarter of 2024.

This dividend will be disbursed on September 4, 2024, to all shareholders of record as of July 18, 2024. The company continues its commitment to returning value to its shareholders through regular dividend payments.

Zoetis (NYSE: ZTS) will attend the William Blair 44th Annual Growth Stock Conference on June 4, 2024.

Wetteny Joseph, Executive Vice President and CFO, will represent the company and answer analysts' questions. His presentation is scheduled for 2:40 p.m. CT.

Investors and interested parties can access the live audio webcast of the presentation via the Zoetis investor relations website. A replay will be available following the event.

Zoetis (NYSE: ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on May 29, 2024. Kristin Peck, CEO, will represent the company and respond to analysts' questions. Her presentation is scheduled for 12:05 p.m. ET and will be available via a live audio webcast on the Zoetis investor website. A replay will also be accessible after the event.

Zoetis Inc. (NYSE:ZTS) reported a successful first quarter of 2024 with revenue of $2.2 billion, a 10% increase YoY. Net income was $599 million, or $1.31 per diluted share, up 9% and 10%, respectively. Adjusted net income was $634 million, or $1.38 per diluted share. The company updated its full-year 2024 revenue guidance to $9.050 - $9.200 billion, showing operational revenue growth of 8.5% to 10.5%. Zoetis continues to invest in innovation and growth, expanding product franchises globally.

Zoetis Inc. (NYSE:ZTS) has entered into a definitive agreement with Phibro Animal Health (Nasdaq: PAHC), where the latter will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products, and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024. The portfolio, generating approximately $400 million in revenue in 2023, comprises more than 37 product lines sold in around 80 countries, spanning across six manufacturing sites. More than 300 Zoetis colleagues will transition to Phibro Animal Health. The divestiture allows Zoetis to focus its livestock investments in other areas, such as vaccine, biologic, and genetic programs. The acquisition is expected to boost Phibro Animal Health’s sales and profitability significantly.

The Zoetis Foundation is championing global veterinarian education, well-being, and livelihoods on World Veterinary Day and beyond by providing grant support to initiatives promoting veterinary education, mental well-being, and livelihoods. The Foundation has committed $18.7 million to advance opportunities for veterinarians and farmers worldwide, fund humanitarian relief efforts, and support colleague matching gifts. Key grantees include the American Association of Veterinary Medical Colleges, the Federation of Veterinarians of Europe, and the World Food Program.